Regencell Bioscience Holdings RGC
NASDAQ RGC
$6.82 +0.49 (+7.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regencell Bioscience Holdings (RGC) Price to Book (2022 - 2025)

Updated

Regencell Bioscience Holdings' (RGC) Price to Book was 224.11 for the quarter ended Dec 31, 2025.

Analysis

Regencell Bioscience Holdings (RGC) Price to Book (2022 - 2025) Analysis & Trends

For the year ended Jun 30, 2025, Price to Book at Regencell Bioscience Holdings was 45.62.

  • By year, Price to Book came in at 0.14 in the year ended Jun 30, 2024 (-78.5%), 0.66 in the year ended Jun 30, 2023 (-4.5%) and 0.69 in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Regencell Bioscience Holdings 88.75 Mn 81.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 224.11
Jun 30, 2025 45.62
Jun 30, 2024 0.14
Jun 30, 2023 0.66
Jun 30, 2022 0.69
API Access

Regencell Bioscience Holdings Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=RGC&period=max&api_key=YOUR_API_KEY